Vincent J. Miles

Vincent J.
Miles currently works at Abingworth Management, Inc., as Executive Director from 2022, IFM Therapeutics LLC, as Director, and Abingworth Management Ltd., as Partner.
Dr. Miles also formerly worked at PrimeraDx, Inc., as Interim President & Chief Executive Officer in 2010, Chiasma, Inc., as Independent Director from 2012 to 2015, Dicerna Pharmaceuticals, Inc., as Independent Director in 2014, Personalis, Inc., as Director, Dana-Farber Cancer Institute, Inc., as Director-Technology Transfer Office, Magellan Diagnostics, Inc., as Director, Hydra Biosciences, Inc., as Director, Novartis Inflammasome Research, Inc., as Director, Millennium Pharmaceuticals, Inc., as VP-Business Development & Technology Management, RiboGene, Inc., as Vice President-Research & Development, Alnylam Pharmaceuticals, Inc., as Senior Vice President-Business Development, Pharmacia Biotech (Biochrom) Ltd., as Vice President-International Marketing, and GE Healthcare Ltd. (United Kingdom), as Research & Development Scientist.
Dr. Miles received his undergraduate degree and doctorate degree from University College London.